posted by user: Rachel || 1061 views || tracked by 2 users: [display]

Free Cell Press Webinar 2015 : Cancer Immunoediting: Implications for Cancer Immunotherapy

FacebookTwitterLinkedInGoogle

Link: http://view6.workcast.net/register?pak=1147739887088638
 
When Mar 12, 2015 - Mar 12, 2015
Where Online webinar
Submission Deadline TBD
Categories    cancer   immunotherapy   immunoediting
 

Call For Papers

While the immune system attempts to constrain tumor growth, tumor cells often escape this immune pressure, in a manner similar to tumor cell evasion of classic tumor suppression mechanisms. The dual host-protective and tumor-promoting actions of immunity are referred to as cancer immunoediting. Cancer immunoediting emphasizes that extrinsic immune pressure either can block tumor growth, development, and survival or can facilitate tumor outgrowth by shaping tumor immunogenicity and inhibiting host-protective antitumor responses. In this webinar, Nir Hacohen and Robert Schreiber discuss recent advances in our understanding of cancer immunoediting and the implications for cancer immunotherapy.

Related Resources

Cancer, Inflammation and Immunity 2017   Cell Symposium: Cancer, Inflammation, and Immunity
Networks of the Future 2017   Call for book chapters- Networks of the Future (Internet of Things, Cloud Computing, SDN, Big Data, 5G) CRC Press (extended)
CfP SI SPE Journal (Wiley Press) 2017   CfP SI Metaheuristics in Cloud Computing - Journal of Software: Practice and Experience (Wiley Press)
Call for Book Chapters 2017   DEEP LEARNING FOR IMAGE PROCESSING APPLICATIONS
CoMeSySo 2017   Computational Methods in Systems and Software 2017
Press Start - Body Movements 2017   Press Start - 'Body Movements' Special Issue
NZBCS 2017   The New Zealand Breast Cancer Symposium - United for a Cure Through Research
Free VLSI Workshop 2017   Registrations open – Free VLSI Workshop at Maven Silicon on 20th Aug 2017
MIAM 2018   Miami Winter Symposium 2018 - Stem Cells
CRISPR 2017   Cell Symposium CRISPR: From Biology to Technology and Novel Therapeutics